The absolute risk appears low, but new data suggest small changes in smell and taste with GLP-1 treatment may exceed those already associated with type 2 diabetes.
Researchers say that GLP-1 drugs like Ozempic used to treat type 2 diabetes may impair a person’s sense of taste and smell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results